查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
體外肺模型市場：成長、未來前景、競爭分析，2024-2032 年
市場調查報告書
商品編碼
1517845

體外肺模型市場：成長、未來前景、競爭分析，2024-2032 年

In Vitro Lung Model Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
出版日期: | 出版商: Acute Market Reports | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

體外肺模型市場是醫學研究和生物技術廣泛領域中的一個特殊領域。該市場專注於模擬人類肺結構和功能的體外模型的開發、生產和利用。這些模型對於呼吸研究、藥物發現和毒性測試等各種應用至關重要。預計 2024 年至 2032 年，體外肺模型市場將以 17.2% 的複合年增長率成長。體外肺模型是模仿人類肺部生物學特性的實驗室模型。它將使用多種技術進行開發，包括細胞培養、器官晶片技術和 3D 生物列印。這些模型旨在重現肺部的細胞環境、結構特徵和生理反應，為傳統動物實驗提供更準確、更合乎倫理的替代方案。

促進因素：對先進呼吸系統疾病研究的需求不斷增加

體外肺模型市場的主要驅動力是對先進呼吸系統疾病研究日益增長的需求。這項需求是由慢性阻塞性肺病 (COPD)、氣喘和肺癌等呼吸道疾病在全球日益流行所推動的。根據世界衛生組織 (WHO) 的數據，慢性阻塞性肺病 (COPD) 是世界第三大死因，而氣喘則影響著全球數百萬人。呼吸系統疾病負擔的增加需要更有效的研究工具來瞭解疾病機制、開發新的治療方法並改善患者的治療結果。體外肺模型提供了一種有前途的解決方案，它為動物實驗提供了更準確和道德的替代方案，並允許在細胞和分子層面上對肺部疾病進行詳細研究。隨著世界各地的科學家利用體外肺模型來研究病毒對肺組織的影響並測試潛在的治療方法，COVID-19 大流行進一步強化了肺部研究的重要性。這凸顯了這些模型在呼吸系統疾病研究和藥物開發中的重要作用，推動了市場的顯著成長。

機會：肺模型的技術進步

由於肺部模型開發的技術進步，體外肺模型市場提供了巨大的機會。 3D 生物列印和器官晶片技術等創新正在徹底改變該領域，從而能夠創建更複雜且與生理相關的肺部模型。這些進步不僅提高了藥物療效和毒性測試的準確性，也為個人化醫療開闢了新途徑。例如，使用來自特定患者的細胞開發肺部模型的能力可能會實現更個性化的藥物反應測試和客製化治療的發展。這些技術進步符合個人化醫療和精準醫療的成長趨勢，為市場成長創造了利潤豐厚的機會。隨著這些技術的不斷成熟和變得更加容易獲得，體外肺模型的應用和功能預計將顯著擴展。

抑制因素：成本高、技術複雜

儘管體外肺模型具有潛力，但該市場面臨高成本和技術複雜性的主要限制因素。開發和維護複雜的肺部模型，特別是那些使用晶片器官等尖端技術的模型，需要大量的財務投資。這些技術相關的高成本可能會對學術機構和小型研究機構構成障礙，限制先進肺模型的傳播。此外，創建和使用這些模型所涉及的技術複雜性需要專門的專業知識和資源。這不僅增加了成本，而且限制了能夠有效利用這些模型進行研究目的的熟練專業人員的可用性。因此，先進體外肺部模型的高成本和技術複雜性仍然是市場上的主要課題，並可能阻礙更廣泛的採用和創新。

課題：再現人肺的複雜性

體外肺模型市場面臨的最大課題之一是重建人類肺部的複雜結構。肺部是一個高度複雜的器官，具有獨特的結構和多樣化的細胞類型，因此很難在實驗室中準確模擬。儘管最近的技術進步在這一領域取得了重大進展，但目前體外模型的能力與真實人類肺部的複雜性之間仍然存在差距。這個問題極為重要，因為肺模型在研究和藥物開發中的有效性很大程度上取決於它們再現人類肺生理和病理的準確程度。克服這項課題需要持續的研究和創新，以開發更複雜的模型，能夠忠實地模擬人類肺部的複雜結構、細胞多樣性和動態生理反應。解決這個問題對於體外肺模型在呼吸研究中的持續進步和實用至關重要。

市場區隔：依類型

在體外肺模型市場中，依類型細分包括2D模型和3D模型，每種模型都有不同的成長模式和收入貢獻。 3D模型目前佔市場銷售量最高。這項優勢歸功於 3D 模型能夠忠實再現人類肺部結構和功能的先進能力，使其在藥物發現和疾病建模的複雜研究中具有極高的價值。與傳統的 2D 文化相比，它在先進的研究環境中被廣泛採用，因為它提供了更生理相關的環境。 3D 模型在複雜性肺部疾病研究和呼吸系統藥物療效測試中的使用不斷增加，進一步增強了其收入優勢。然而，預計複合年增長率 (CAGR) 最高的是 2D 建模領域。雖然 3D 模型提供了高級功能，但 2D 模型由於其簡單、成本低且易於使用，仍然被廣泛使用。對 2D 模型的需求預計將成長，特別是基礎研究和日常檢查，這可能不需要 3D 模型的複雜性和成本。

市場區隔：依應用劃分

依應用劃分的市場細分包括藥物發現/毒性研究、生理研究、3D模型開發等。由於這些模型在製藥業中發揮的重要作用，藥物發現和毒理學研究領域產生了最高的收入。這些模型廣泛用於潛在候選藥物的篩選和毒性評估，顯著減少與藥物開發相關的時間和成本。藥物研發投資的增加以及對新型呼吸系統藥物的需求不斷增加，特別是在 COVID-19 大流行之後，正在推動該領域的成長。就複合年增長率最高而言，生理學研究領域預計將成長最快。這種增長是由對從根本上瞭解複雜肺部疾病的日益增長的需求所推動的，包括對慢性阻塞性肺病、氣喘和肺癌等疾病的病理生理學的研究。隨著科學界對這些疾病的瞭解不斷增加，對模擬人類肺部生理學的更複雜、更準確的模型的需求預計將顯著增加生理研究中對體外肺模型的需求。

區域洞察

體外肺模型市場的地理細分凸顯了不同地區不同的成長和收入模式。 2023 年，北美成為該市場最賺錢的地區。這一領先地位歸功於該地區先進的醫療保健研究基礎設施、對研發的大量投資以及從事肺部相關研究的主要製藥和生物技術公司的存在。北美呼吸系統疾病的高盛行率以及我們對開發創新治療解決方案的專注也促成了北美的壓倒性銷售。預計 2024 年至 2032 年，亞太地區的複合年增長率 (CAGR) 最高。這項成長預測的推動因素包括中國和印度等國家對醫療保健研究投資的增加、呼吸系統疾病盛行率的上升以及對先進研究技術的認識的提高。此外，擴大醫療基礎設施和增加政府對這些地區生物技術研究的支持可能會促進體外肺模型市場的成長。

競爭趨勢

就競爭趨勢而言，市場的特徵是既有成熟企業，也有新興企業，每個企業都採取獨特的策略來鞏固其市場地位。到 2023 年，Epithelix、MATTEK、Lonza、Emulate、AlveoliX AG、Nortis、CN Bio Innovations、MIMETAS、InSphero 和 ATTC Global 等公司將成為頂級參與者，利用其強大的研究能力和強大的產品組合擴大其主導地位市場。這些公司專注於策略聯盟、併購和收購，以擴大其技術能力和市場覆蓋範圍。在2024年至2032年的預測期內，這些領先公司預計將繼續強調技術創新，特別是在3D生物列印和器官晶片技術等領域。投資這些先進技術預計將成為保持競爭力的重要策略。此外，這些公司將擴大在新興市場的影響力，同時適應不斷變化的研究需求和監管環境。專門從事創新肺部模型技術的新進入者的進入預計將加劇市場競爭，並促進體外肺部模型領域的持續發展。

本報告回答的主要問題

影響體外肺模型市場成長的關鍵微觀和宏觀環境因素有哪些？

現在和預測期內產品細分和地區的主要投資領域是什麼？

2032 年之前的預估與市場預測

預測期間哪個細分市場的複合年增長率最快？

哪個細分市場擁有較大的市場佔有率，為什麼？

低收入和中等收入國家是否正在投資體外肺模型市場？

體外肺模型市場最大的區域市場是哪一個？

亞太地區、拉丁美洲和中東/非洲等新興市場的市場趨勢和動態是什麼？

推動體外肺模型市場成長的主要趨勢是什麼？

主要競爭對手是什麼？

目錄

第一章前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 主要優惠
  • 市場區隔
  • 調查方法
    • 第一階段-二次調查
    • 第二階段 - 初步調查
    • 第三階段-專家評審
    • 先決條件
    • 採用的方法

第 2 章執行摘要

第三章體外肺模型市場：競爭分析

  • 主要供應商的市場定位
  • 供應商採取的策略
  • 主要產業戰略
  • 層級分析：2023 年與 2032 年

第四章體外肺模型市場：宏觀分析與市場動態

  • 簡介
  • 2022-2032年全球體外肺模型市場價值
  • 市場動態
    • 市場驅動因素
    • 市場限制因素
    • 主要課題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析
  • 波特的五力模型
    • 供應商實力
    • 買家力量
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的對抗關係
  • PESTEL 分析
    • 政治局勢
    • 經濟情勢
    • 技術狀況
    • 法律狀況
    • 社會狀況

第五章體外肺模型市場：依類型2022-2032

  • 市場概覽
  • 成長/利潤分析：2023 年與 2032 年
  • 市場區隔
    • 二維模型
    • 3D模型

第六章體外肺模型市場：依應用劃分2022-2032

  • 市場概覽
  • 成長/利潤分析：2023 年與 2032 年
  • 市場區隔
    • 藥物發現/毒性研究
    • 生理研究
    • 3D模型開發
    • 其他

第七章體外肺模型市場：依最終用途 2022-2032

  • 市場概覽
  • 成長/利潤分析：2023 年與 2032 年
  • 市場區隔
    • 學術研究所
    • 製藥和生技公司
    • 其他

第八章2022-2032年北美體外肺模型市場

  • 市場概覽
  • 體外肺模型市場：依類型劃分2022-2032年
  • 體外肺模型市場：依應用劃分2022-2032年
  • 2022-2032 年依最終用途劃分的體外肺模型市場
  • 體外肺模型市場：依地區劃分2022-2032年
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第 9 章英國/歐盟體外肺模型市場 2022-2032

  • 市場概覽
  • 體外肺模型市場：依類型劃分2022-2032年
  • 體外肺模型市場：依應用劃分2022-2032年
  • 2022-2032 年依最終用途劃分的體外肺模型市場
  • 體外肺模型市場：依地區劃分2022-2032年
    • 英國/歐盟
      • 英國
      • 德國
      • 西班牙
      • 義大利
      • 法國
      • 其他歐洲地區

第十章亞太體外肺模型市場2022-2032

  • 市場概覽
  • 體外肺模型市場：依類型劃分2022-2032年
  • 體外肺模型市場：依應用劃分2022-2032年
  • 2022-2032 年依最終用途劃分的體外肺模型市場
  • 體外肺模型市場：依地區劃分2022-2032年
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區

第11章2022-2032年拉丁美洲體外肺模型市場

  • 市場概覽
  • 體外肺模型市場：依類型劃分2022-2032年
  • 體外肺模型市場：依應用劃分2022-2032年
  • 2022-2032 年依最終用途劃分的體外肺模型市場
  • 體外肺模型市場：依地區劃分2022-2032年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第十二章中東與非洲體外肺模型市場2022-2032

  • 市場概覽
  • 體外肺模型市場：依類型劃分2022-2032年
  • 體外肺模型市場：依應用劃分2022-2032年
  • 2022-2032 年依最終用途劃分的體外肺模型市場
  • 體外肺模型市場：依地區劃分2022-2032年
    • 中東/非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東/非洲地區

第十三章公司簡介

  • Epithelix
  • MATTEK
  • Lonza
  • Emulate
  • AlveoliX AG
  • Nortis
  • CN Bio Innovations Ltd.
  • MIMETAS
  • InSphero
  • ATTC Global
  • 其他主要公司
Product Code: 527-07-24

The in vitro lung model market is a specialized segment within the broader field of medical research and biotechnology. This market focuses on the development, production, and utilization of in vitro (outside the living organism) models that simulate the structure and function of human lungs. These models are crucial for various applications in respiratory research, drug discovery, and toxicology testing. The in vitro lung model market is estimated to grow at a CAGR of 17.2% from 2024 to 2032. In vitro lung models are laboratory models that mimic the biological characteristics of human lungs. They are developed using various techniques, including cell cultures, organ-on-a-chip technology, and 3D bioprinting. These models aim to replicate the lung's cellular environment, structural features, and physiological responses, providing a more accurate and ethical alternative to traditional animal testing.

Driver: Growing Need for Advanced Respiratory Disease Research

The in vitro lung model market is primarily driven by the growing need for advanced respiratory disease research. This demand is fueled by the increasing prevalence of respiratory diseases globally, including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. According to the World Health Organization, COPD alone is the third leading cause of death worldwide, and asthma affects millions of people globally. This rising burden of respiratory diseases necessitates more effective research tools for understanding disease mechanisms, developing new treatments, and improving patient outcomes. In vitro lung models offer a promising solution by providing a more accurate and ethical alternative to animal testing, enabling detailed study of lung diseases at the cellular and molecular level. The COVID-19 pandemic further highlighted the importance of lung research, as scientists worldwide turned to in vitro lung models to study the virus's effects on lung tissue and test potential treatments. This has underscored the essential role of these models in respiratory disease research and drug development, driving significant growth in the market.

Opportunity: Technological Advancements in Lung Models

The in vitro lung model market presents significant opportunities with technological advancements in lung model development. Innovations such as 3D bioprinting and organ-on-a-chip technology are revolutionizing the field, enabling the creation of more complex and physiologically relevant lung models. These advancements are not only enhancing the accuracy of drug efficacy and toxicity testing but also opening new avenues in personalized medicine. For instance, lung models can now be developed using cells from specific patients, allowing for more personalized drug response testing and the potential development of customized treatments. This technological evolution aligns with the growing trend towards personalized healthcare and precision medicine, making it a lucrative opportunity for market growth. As these technologies continue to mature and become more accessible, they are expected to significantly expand the applications and capabilities of in vitro lung models.

Restraint: High Costs and Technical Complexities

Despite the potential of in vitro lung models, the market faces significant restraints in terms of high costs and technical complexities. Developing and maintaining sophisticated lung models, especially those using cutting-edge technologies like organ-on-a-chip, requires substantial financial investment. The high costs associated with these technologies can be a barrier for academic and smaller research institutions, limiting the widespread adoption of advanced lung models. Additionally, the technical complexities involved in creating and using these models require specialized expertise and resources. This not only adds to the cost but also limits the availability of skilled professionals who can effectively utilize these models for research purposes. As such, the high cost and technical complexity of advanced in vitro lung models remain major challenges in the market, potentially hindering broader adoption and innovation.

Challenge: Replicating the Complexity of Human Lungs

One of the biggest challenges in the in vitro lung model market is replicating the intricate complexity of human lungs. The lung is a highly complex organ with a unique structure and diverse cell types, making it difficult to accurately mimic in a laboratory setting. While recent technological advancements have made significant strides in this area, there is still a gap between the current capabilities of in vitro models and the complexity of real human lungs. This challenge is critical because the efficacy of lung models in research and drug development heavily depends on how accurately they replicate human lung physiology and pathology. Overcoming this challenge requires ongoing research and innovation to develop more sophisticated models that can closely mimic the intricate architecture, cellular diversity, and dynamic physiological responses of human lungs. Addressing this issue is essential for the continued advancement and utility of in vitro lung models in respiratory research.

Market segmentation by type

In the in vitro lung model market, segmentation by type includes 2D and 3D Models, each with distinct growth patterns and revenue contributions. The 3D Model segment currently holds the highest revenue within this market. This prominence is due to the advanced capabilities of 3D models in closely replicating the structural and functional aspects of human lungs, making them highly valuable for complex studies in drug discovery and disease modeling. Their ability to provide a more physiologically relevant environment compared to traditional 2D cultures has led to their widespread adoption in advanced research settings. The revenue dominance of 3D models is further reinforced by their increasing use in studying intricate lung diseases and testing the efficacy of respiratory drugs. However, the segment expected to exhibit the highest Compound Annual Growth Rate (CAGR) is the 2D Model segment. While 3D models offer advanced features, 2D models are still widely used due to their simplicity, lower cost, and ease of use. The demand for 2D models is expected to grow, particularly in basic research and routine testing, where the complexity and cost of 3D models may not be necessary.

Market Segmentation by Application

Regarding market segmentation by application, the in vitro lung model market includes Drug Discovery & Toxicology Studies, Physiological Research, 3D Model Development, among others. The Drug Discovery & Toxicology Studies segment has generated the highest revenue, attributed to the critical role these models play in the pharmaceutical industry. They are extensively used for screening potential drug candidates and assessing their toxicity, significantly reducing the time and cost associated with drug development. The increasing investment in pharmaceutical R&D, along with the rising demand for new respiratory drugs, especially post the COVID-19 pandemic, has fueled the growth of this segment. In terms of the highest CAGR, the Physiological Research segment is projected to grow rapidly. This growth is driven by the escalating need to understand complex lung diseases at a fundamental level, including studying the pathophysiology of conditions like COPD, asthma, and lung cancers. As the scientific community's understanding of these diseases deepens, the demand for in vitro lung models in physiological research is expected to increase significantly, driven by the need for more sophisticated and accurate models to mimic human lung physiology.

Regional Insights

The in vitro lung model market's geographic segmentation highlights varied growth and revenue patterns across different regions. In 2023, North America emerged as the region with the highest revenue in this market. This leadership can be attributed to the region's advanced healthcare research infrastructure, significant investments in R&D, and the presence of key pharmaceutical and biotech companies engaged in lung-related research. The high prevalence of respiratory diseases and the strong focus on developing innovative treatment solutions in North America further contributed to its dominant revenue position. Looking towards 2024 to 2032, the Asia-Pacific region is expected to experience the highest Compound Annual Growth Rate (CAGR). This growth projection is driven by increasing investments in healthcare research, rising incidence of respiratory diseases, and growing awareness of advanced research methodologies in countries like China and India. Additionally, the expanding healthcare infrastructure and increasing government support for biotechnology research in these regions are likely to fuel the growth of the in vitro lung model market.

Competitive Trends

In terms of competitive trends, the market is characterized by a mix of established players and emerging entrants, each employing distinct strategies to strengthen their market positions. In 2023, companies such as Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd., MIMETAS, InSphero, ATTC Global were among the top players, leveraging their extensive research capabilities and robust product portfolios to dominate the market. These companies focused on strategic collaborations, mergers, and acquisitions to broaden their technological capabilities and enhance their market reach. For the forecast period of 2024 to 2032, these key players are expected to continue emphasizing innovation, particularly in areas like 3D bioprinting and organ-on-a-chip technologies. Investment in these advanced technologies is anticipated to be a crucial strategy for maintaining a competitive edge. Furthermore, these companies are likely to expand their presence in emerging markets, adapting to the evolving research needs and regulatory landscapes. The entry of new players specializing in innovative lung model technologies is expected to intensify competition in the market, thereby driving continuous advancements in the field of in vitro lung models.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of In Vitro Lung Model market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the In Vitro Lung Model market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

Type

2D Model

3D Model

Application

    • Drug Discovery & Toxicology Studies
    • Physiological Research

3D Model Development

    • Others

End-Use

    • Academic Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Others

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of In Vitro Lung Model market?

What are the key investment pockets concerning product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the In Vitro Lung Model market?

Which is the largest regional market for In Vitro Lung Model market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving In Vitro Lung Model market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the In Vitro Lung Model market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global In Vitro Lung Model Market
  • 2.2. Global In Vitro Lung Model Market, By Type, 2023 (US$ Million)
  • 2.3. Global In Vitro Lung Model Market, By Application, 2023 (US$ Million)
  • 2.4. Global In Vitro Lung Model Market, By End-Use, 2023 (US$ Million)
  • 2.5. Global In Vitro Lung Model Market, By Geography, 2023 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2023

3. In Vitro Lung Model Market: Competitive Analysis

  • 3.1. Market Positioning of Key In Vitro Lung Model Market Vendors
  • 3.2. Strategies Adopted by In Vitro Lung Model Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. In Vitro Lung Model Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global In Vitro Lung Model Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. 2D Model
    • 5.3.2. 3D Model

6. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Drug Discovery & Toxicology Studies
    • 6.3.2. Physiological Research
    • 6.3.3. 3D Model Development
    • 6.3.4. Others

7. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Market Segmentation
    • 7.3.1. Academic Research Institutes
    • 7.3.2. Pharmaceutical & Biotechnology Companies
    • 7.3.3. Others

8. North America In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 8.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 8.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 8.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

9. UK and European Union In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 9.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 9.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 9.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.4.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.4.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.5.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.5.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.6.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.6.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

10. Asia Pacific In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 10.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 10.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 10.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.4.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.4.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.5.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.5.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.6.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.6.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

11. Latin America In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 11.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 11.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 11.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

12. Middle East and Africa In Vitro Lung Model Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
  • 12.3. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
  • 12.4. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
  • 12.5.In Vitro Lung Model Market: By Region, 2022-2032, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.1.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.1.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.2.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.2.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. In Vitro Lung Model Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.3.2. In Vitro Lung Model Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.3.3. In Vitro Lung Model Market: By End-Use, 2022-2032, USD (Million)

13. Company Profile

  • 13.1. Epithelix
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. MATTEK
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Lonza
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Emulate
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. AlveoliX AG
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Nortis
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. CN Bio Innovations Ltd.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. MIMETAS
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. InSphero
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. ATTC Global
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Other Notable Players
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 2 Global In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 3 Global In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 4 North America In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 5 North America In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 6 North America In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 7 U.S. In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 8 U.S. In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 9 U.S. In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 10 Canada In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 11 Canada In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 12 Canada In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 13 Rest of North America In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 14 Rest of North America In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 15 Rest of North America In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 16 UK and European Union In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 17 UK and European Union In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 18 UK and European Union In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 19 UK In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 20 UK In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 21 UK In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 22 Germany In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 23 Germany In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 24 Germany In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 25 Spain In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 26 Spain In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 27 Spain In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 28 Italy In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 29 Italy In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 30 Italy In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 31 France In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 32 France In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 33 France In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 34 Rest of Europe In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 35 Rest of Europe In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 36 Rest of Europe In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 37 Asia In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 38 Asia In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 39 Asia In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 40 China In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 41 China In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 42 China In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 43 Japan In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 44 Japan In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 45 Japan In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 46 India In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 47 India In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 48 India In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 49 Australia In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 50 Australia In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 51 Australia In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 52 South Korea In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 53 South Korea In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 54 South Korea In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 55 Latin America In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 56 Latin America In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 57 Latin America In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 58 Brazil In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 59 Brazil In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 60 Brazil In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 61 Mexico In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 62 Mexico In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 63 Mexico In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 64 Rest of Latin America In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 65 Rest of Latin America In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 66 Rest of Latin America In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 67 Middle East and Africa In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 68 Middle East and Africa In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 69 Middle East and Africa In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 70 GCC In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 71 GCC In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 72 GCC In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 73 Africa In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 74 Africa In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 75 Africa In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)
  • TABLE 76 Rest of Middle East and Africa In Vitro Lung Model Market By Type, 2022-2032, USD (Million)
  • TABLE 77 Rest of Middle East and Africa In Vitro Lung Model Market By Application, 2022-2032, USD (Million)
  • TABLE 78 Rest of Middle East and Africa In Vitro Lung Model Market By End-Use, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global In Vitro Lung Model Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global In Vitro Lung Model Market: Quality Assurance
  • FIG. 5 Global In Vitro Lung Model Market, By Type, 2023
  • FIG. 6 Global In Vitro Lung Model Market, By Application, 2023
  • FIG. 7 Global In Vitro Lung Model Market, By End-Use, 2023
  • FIG. 8 Global In Vitro Lung Model Market, By Geography, 2023
  • FIG. 9 Market Geographical Opportunity Matrix - Global In Vitro Lung Model Market, 2023

FIG. 10Market Positioning of Key In Vitro Lung Model Market Players, 2023

FIG. 11Global In Vitro Lung Model Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 12 Global In Vitro Lung Model Market, By Type, 2023 Vs 2032, %
  • FIG. 13 Global In Vitro Lung Model Market, By Application, 2023 Vs 2032, %
  • FIG. 14 Global In Vitro Lung Model Market, By End-Use, 2023 Vs 2032, %
  • FIG. 15 U.S. In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 16 Canada In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 17 Rest of North America In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 18 UK In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 19 Germany In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 20 Spain In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 21 Italy In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 22 France In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 23 Rest of Europe In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 24 China In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 25 Japan In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 26 India In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 27 Australia In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 28 South Korea In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 29 Rest of Asia In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 30 Brazil In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 31 Mexico In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 32 Rest of Latin America In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 33 GCC In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 34 Africa In Vitro Lung Model Market (US$ Million), 2022 - 2032
  • FIG. 35 Rest of Middle East and Africa In Vitro Lung Model Market (US$ Million), 2022 - 2032